Biomedical applications of sheep models: from asthma to vaccines.

[1]  W. Abraham,et al.  Characterization of a late phase pulmonary response after antigen challenge in allergic sheep. , 2015, The American review of respiratory disease.

[2]  L. Mendonça-Hagler,et al.  Trends in biotechnology and biosafety in Brazil. , 2008, Environmental biosafety research.

[3]  P. Giunchedi,et al.  Spray-dried microspheres based on methylpyrrolidinone chitosan as new carrier for nasal administration of metoclopramide. , 2008, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[4]  Paolo Giannoni,et al.  A tissue engineering approach to bone repair in large animal models and in clinical practice. , 2007, Biomaterials.

[5]  W. Davis,et al.  Cross-reactivity of mAbs to human CD antigens with sheep leukocytes. , 2007, Veterinary immunology and immunopathology.

[6]  Wei Yang Lu,et al.  Experimental ovine model of primary venous valve incompetence: a pilot study. , 2007, Journal of vascular and interventional radiology : JVIR.

[7]  F. Arko,et al.  Device-Specific Resistance to in Vivo Displacement of Stent-Grafts Implanted with Maximum Iliac Fixation , 2007, Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists.

[8]  F. Keller,et al.  Percutaneous autologous venous valve transplantation: short-term feasibility study in an ovine model. , 2007, Journal of vascular surgery.

[9]  J. Maddox,et al.  An update on sheep and goat linkage maps and other genomic resources , 2007 .

[10]  B. Piedboeuf,et al.  Tracheal occlusion: A review of obstructing fetal lungs to make them grow and mature , 2007, American journal of medical genetics. Part C, Seminars in medical genetics.

[11]  Ajay K. Singh,et al.  Hemoglobin maintenance with use of extended dosing of epoetin alfa in patients with diabetes and anemia of chronic kidney disease. , 2007, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

[12]  J. Scheerlinck,et al.  Co-delivery of plasmid-encoded cytokines modulates the immune response to a DNA vaccine delivered by in vivo electroporation. , 2007, Vaccine.

[13]  L. Illum.  Nanoparticulate systems for nasal delivery of drugs: a real improvement over simple systems? , 2007, Journal of pharmaceutical sciences.

[14]  L. Guilloteau,et al.  Differential expression of homing receptors and vascular addressins in tonsils and draining lymph nodes: Effect of Brucella infection in sheep. , 2007, Veterinary immunology and immunopathology.

[15]  D. Sampson,et al.  In vitro and in vivo tissue repair with laser‐activated chitosan adhesive , 2007, Lasers in surgery and medicine.

[16]  S. Edwards,et al.  Local immune responses following nasal delivery of an adjuvanted influenza vaccine. , 2006, Vaccine.

[17]  D. Piedrafita,et al.  DNA vaccines in sheep: CTLA-4 mediated targeting and CpG motifs enhance immunogenicity in a DNA prime/protein boost strategy. , 2006, Vaccine.

[18]  E. Meeusen,et al.  The ovine nasal mucosa: an alternative tissue site for mucosal immunization. , 2006, Methods.

[19]  S. Rees,et al.  Chronic Endotoxin Exposure Causes Brain Injury in the Ovine Fetus in the Absence of Hypoxemia , 2006, The Journal of the Society for Gynecologic Investigation: JSGI.

[20]  J. Scheerlinck,et al.  A sheep cannulation model for evaluation of nasal vaccine delivery. , 2006, Methods.

[21]  P. Giunchedi,et al.  Nasal administration of carbamazepine using chitosan microspheres: in vitro/in vivo studies. , 2006, International journal of pharmaceutics.

[22]  D. Klinman.  Adjuvant Activity of CpG Oligodeoxynucleotides , 2006, International reviews of immunology.

[23]  Emmanuel Koumoundouros,et al.  CHRONIC AIRWAY DISEASE: DETERIORATING PULMONARY FUNCTION IN SHEEP ASSOCIATED WITH REPEATED CHALLENGES OF HOUSE DUST MITE , 2006, Experimental lung research.

[24]  M. Johnston,et al.  Models of Cerebral Palsy , 2005, Journal of child neurology.

[25]  S. Hooper,et al.  Pulmonary function and structure following mild preterm birth in lambs , 2005, Pediatric pulmonology.

[26]  A. M. Dyer,et al.  Intranasal delivery of recombinant human growth hormone (somatropin) in sheep using chitosan-based powder formulations. , 2005, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[27]  J. Scheerlinck,et al.  Prolongation of Sheep Corneal Allograft Survival by Transfer of the Gene Encoding Ovine IL-12-p40 but Not IL-4 to Donor Corneal Endothelium1 , 2005, The Journal of Immunology.

[28]  W. Van den Broeck,et al.  Anatomical localisation and histology of the ovine tonsils. , 2005, Veterinary immunology and immunopathology.

[29]  K. Campbell,et al.  Cloning: eight years after Dolly. , 2005, Reproduction in domestic animals = Zuchthygiene.

[30]  I. Jabbal‐Gill,et al.  Effect of chitosan on the intranasal absorption of salmon calcitonin in sheep , 2005, The Journal of pharmacy and pharmacology.

[31]  Steven W. Martin,et al.  Lymphatic Absorption Is the Primary Contributor to the Systemic Availability of Epoetin Alfa following Subcutaneous Administration to Sheep , 2005, Journal of Pharmacology and Experimental Therapeutics.

[32]  J. Arezzo,et al.  A Randomized, Double-Blinded, Placebo-Controlled Phase II Trial of Recombinant Human Leukemia Inhibitory Factor (rhuLIF, Emfilermin, AM424) to Prevent Chemotherapy-Induced Peripheral Neuropathy , 2005, Clinical Cancer Research.

[33]  K. Snibson,et al.  Airway remodelling and inflammation in sheep lungs after chronic airway challenge with house dust mite , 2005, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[34]  D. Buxton,et al.  Intranasal immunisation with Toxoplasma gondii tachyzoite antigen encapsulated into PLG microspheres induces humoral and cell-mediated immunity in sheep. , 2004, Vaccine.

[35]  M. Mitchell,et al.  Autoaugmentation gastrocystoplasty: further studies of the sheep model , 2004, BJU international.

[36]  Donald E Mager,et al.  Pharmacokinetics of Recombinant Human Leukemia Inhibitory Factor in Sheep , 2004, Journal of Pharmacology and Experimental Therapeutics.

[37]  C. Hughes,et al.  Of Mice and Not Men: Differences between Mouse and Human Immunology , 2004, The Journal of Immunology.

[38]  P. Herijgers,et al.  A new model to test the calcification characteristics of bioprosthetic heart valves. , 2004, Annals of thoracic and cardiovascular surgery : official journal of the Association of Thoracic and Cardiovascular Surgeons of Asia.

[39]  S. Davis,et al.  The Effect of Blood Sampling Site and Physicochemical Characteristics of Drugs on Bioavailability After Nasal Administration in the Sheep Model , 2003, Pharmaceutical Research.

[40]  J. Fredberg,et al.  Murine models of asthma , 2003, European Respiratory Journal.

[41]  G. Edwards,et al.  Implantation of the VentrAssist Implantable Rotary Blood Pump in Sheep , 2003, ASAIO journal.

[42]  P. Gäddlin,et al.  Asthma, lung function and allergy in 12‐year‐old children with very low birth weight: A prospective study , 2003, Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology.

[43]  K. Snibson,et al.  Induction of allergic inflammation in the lungs of sensitized sheep after local challenge with house dust mite , 2003, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[44]  N. James,et al.  Preclinical Trials Of The Ventrassist Rotary Blood Pump In Sheep , 2003 .

[45]  S. Rockman,et al.  Intranasal vaccination with ISCOMATRIX adjuvanted influenza vaccine. , 2003, Vaccine.

[46]  I. Aaberge,et al.  Influence of Intravenous Anesthesia on Mucosal and Systemic Antibody Responses to Nasal Vaccines , 2002, Infection and Immunity.

[47]  L. Bakaletz,et al.  Tracking the tissue distribution of marker dye following intranasal delivery in mice and chinchillas: a multifactorial analysis of parameters affecting nasal retention. , 2002, Vaccine.

[48]  A. M. Dyer,et al.  Nasal Delivery of Insulin Using Novel Chitosan Based Formulations: A Comparative Study in Two Animal Models Between Simple Chitosan Formulations and Chitosan Nanoparticles , 2002, Pharmaceutical Research.

[49]  H. Miller,et al.  Tissue‐specific expression of mast cell granule serine proteinases and their role in inflammation in the lung and gut , 2002, Immunology.

[50]  J. Y. Scheerlinck,et al.  Genetic adjuvants for DNA vaccines. , 2001, Vaccine.

[51]  A. Sjölander,et al.  Induction of lymphocyte recruitment in the absence of a detectable immune response. , 2000, Vaccine.

[52]  J. Seagrave,et al.  Animal models of asthma: potential usefulness for studying health effects of inhaled particles. , 2000, Inhalation toxicology.

[53]  A. Lew,et al.  Site-directed immune responses in DNA vaccines encoding ligand-antigen fusions. , 2000, Vaccine.

[54]  L. Babiuk,et al.  Immunization of animals: from DNA to the dinner plate. , 1999, Veterinary immunology and immunopathology.

[55]  A. Colman.  Dolly, Polly and other 'ollys': likely impact of cloning technology on biomedical uses of livestock. , 1999, Genetic analysis : biomolecular engineering.

[56]  I. Mathiesen.  Electropermeabilization of skeletal muscle enhances gene transfer in vivo , 1999, Gene Therapy.

[57]  A J Young,et al.  The physiology of lymphocyte migration through the single lymph node in vivo. , 1999, Seminars in immunology.

[58]  A. Whyte,et al.  Immunology of the tonsils. , 1998, Immunology today.

[59]  J. Scheerlinck,et al.  Ovine cytokines and their role in the immune response. , 1998, Veterinary research.

[60]  S. Johnston,et al.  Biological features of genetic immunization. , 1997, Vaccine.

[61]  I. M. Richards.  Mouse models of allergic disease; how do they relate to asthma in man? , 1996, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[62]  P. Foster,et al.  Interleukin 5 deficiency abolishes eosinophilia, airways hyperreactivity, and lung damage in a mouse asthma model , 1996, The Journal of experimental medicine.

[63]  Li Wu,et al.  The surface phenotype of dendritic cells purified from mouse thymus and spleen: investigation of the CD8 expression by a subpopulation of dendritic cells , 1992, The Journal of experimental medicine.

[64]  A. Hodson.  Immunology of the Tonsils , 1991, Journal of the Royal Society of Medicine.

[65]  K. Tomioka,et al.  YM461, a PAF antagonist, blocks antigen-induced late airway responses and airway hyperresponsiveness in allergic sheep. , 1989, European journal of pharmacology.

[66]  D. Gardner,et al.  Long-term effects of nutritional programming of the embryo and fetus: mechanisms and critical windows. , 2007, Reproduction, fertility, and development.

[67]  A. Goodship,et al.  Pressor and intra-renal effects of angiotensins I and II, and noradrenaline, in anaesthetized and conscious sheep. The effects of halothane anaesthesia on pressor sensitivity and electrolyte shifts: the proposed use of angiotensin I in treating septicaemia and septic shock. , 2005, Medical hypotheses.

[68]  G. Kraal.  Chapter 23 – Nasal-Associated Lymphoid Tissue , 2005 .

[69]  M. Alley,et al.  Mast cells in the ovine lower respiratory tract: heterogeneity, morphology and density. , 1990, International archives of allergy and applied immunology.

[70]  S. Gizurarson,et al.  Animal models for intranasal drug delivery studies. A review article. , 1990, Acta pharmaceutica Nordica.